Management of Nephrotoxic Antibiotics in Patients with Impaired Renal Function

Introduction to Nephrotoxic Antibiotic Management

When using nephrotoxic antibiotics in patients with impaired renal function, alternative non-nephrotoxic antibiotics should be used whenever possible, and if aminoglycosides must be used, dosing adjustments based on renal function with close monitoring of drug levels and renal function are essential to prevent further kidney damage, as recommended by the Kidney International guidelines 1, 2

Aminoglycosides should not be used for infections unless no suitable, less nephrotoxic therapeutic alternatives are available, according to the Kidney International guidelines 2
Consider the patient's underlying condition, as those with severe hepatic disease may be at greater risk for nephrotoxicity due to predisposition to hepato-renal syndrome, as noted in the MMWR Recommendations and Reports 3

For patients with renal insufficiency, reduce the dosing frequency to 2-3 times per week rather than daily dosing, and maintain the milligram dose at 12-15 mg/kg per dose to take advantage of the concentration-dependent bactericidal effect, as recommended by the MMWR Recommendations and Reports 3, 4
For patients over 59 years of age, reduce the dose to 10 mg/kg per day (maximum 750 mg) even with normal renal function, according to the MMWR Recommendations and Reports 5
In patients on hemodialysis, administer the drug after dialysis to facilitate directly observed therapy and avoid premature removal of the drug, as noted in the MMWR Recommendations and Reports 3, 5

Monitor serum drug concentrations to avoid toxicity, which is essential in patients with renal impairment, as recommended by the MMWR Recommendations and Reports 3
For multiple daily dosing regimens, monitor drug levels when treatment continues for more than 24 hours, according to the Kidney International guidelines 2
For single daily dosing regimens, monitor drug levels when treatment continues for more than 48 hours, as recommended by the Kidney International guidelines 2

Consider topical or local applications of aminoglycosides rather than intravenous administration when feasible, as recommended by the Kidney International guidelines 2
In peritoneal dialysis patients with peritonitis, use non-aminoglycoside antibiotics as retrospective studies have shown greater decrease in residual kidney function with aminoglycoside treatment, according to the American Journal of Kidney Diseases 6, 7

Avoid concurrent use of other nephrotoxic agents with aminoglycosides, including NSAIDs and COX-2 inhibitors, which are particularly harmful in patients with pre-existing renal insufficiency, as noted in the American Journal of Kidney Diseases 7, 8
Avoid concurrent use of amphotericin B with aminoglycosides; instead, use azole antifungals or echinocandins when possible, as recommended by the Kidney International guidelines and the American Journal of Kidney Diseases 1, 8

For patients requiring contrast studies, review the indication and seek alternative studies that don't use contrast, ensure the patient is well-hydrated before the procedure, and consider N-acetylcysteine pre-treatment, though evidence is limited, as recommended by the American Journal of Kidney Diseases 7

Pregnant women should not be given aminoglycosides due to risk of fetal nephrotoxicity and congenital hearing loss, as noted in the MMWR Recommendations and Reports 3
Patients with hepatic disease require no dose adjustment for hepatic impairment alone, but should be monitored for hepato-renal syndrome, according to the MMWR Recommendations and Reports 3

Age over 45-65 years dramatically increases susceptibility to gentamicin-induced renal failure, even with standard dosing, according to the American Heart Association, as reported in Circulation 9
In peritoneal dialysis patients with residual kidney function, retrospective analyses demonstrate that aminoglycoside treatment for peritonitis causes greater decline in kidney function compared to non-aminoglycoside antibiotics, as recommended by the American Journal of Kidney Diseases guidelines 10
The American Journal of Kidney Diseases guidelines explicitly recommend using an antibiotic without the nephrotoxic potential of an aminoglycoside if possible, without compromising antibacterial efficacy, to preserve residual kidney function in dialysis patients 10